MC Services is an international Corporate Communications and Investor Relations firm providing Life Sciences companies high-level consultancy, targeted services and support throughout Europe and beyond
Our Services
Corporate Communications
Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.
Investor Relations
Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.
Roadshows & Transactions
Product & Science PR
Right from its scientific beginnings, and all the way through regulatory approval and market launch we support the strategic positioning and marketing of your product – and the science behind it – to the relevant stakeholders.
SELECTED CLIENTS – PAST AND PRESENT
Client News
PL BioScience Wins Regulatory Certification from Japan’s PMDA
Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board
Lotus Pharmaceutical becomes commercialization partner for Formycon’s Keytruda® biosimilar candidate FYB206 across major parts of the Asia-Pacific Region
MC Services is Media Partner for LSI USA ’26 Medtech & Healthtech Summit
MC Services is proud to serve as media partner for LSI USA ’26, a leading event for medtech and healthtech that unites innovators, investors, and strategic partners shaping the future of medical technology. The summit will take place March 16-20, 2026, in Dana Point, California, bringing together the brightest minds in the industry to drive investment, partnerships, and commercialization of groundbreaking medtech and healthtech innovations.